Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > Submiting questions a few days before the AGM
View:
Post by frebeach1 on Jun 11, 2023 5:16am

Submiting questions a few days before the AGM

I would recommend doing this to avoid off the cuff short answers. Giving them time to reflect should result in a more detailed long answer.

Dave at Bare Oaks Ontario
Comment by Infinity on Jun 11, 2023 7:47am
Yes,  this would show that we are truly interested in the answers and will not benefit from a short off the cuff reply or it they provide a "Non Answer".
Comment by 99942Apophis on Jun 12, 2023 4:49pm
One more question to ask however because of the nature of this question they might consider this one to early or sensitive to answer. Question - Will Theralase be seeking a percentage of sales from each Pharmaceutical partner or can they divulge a rough outline of Theralase's financial arrangement plan for or from the future partnerships? 
Comment by DJDawg on Jun 11, 2023 9:41am
Given that RDW sued people on this site for their comments, I suspect he reads this forum and has been following along with the list of questions :)
Comment by StevenBirch on Jun 11, 2023 10:30am
I agree and I think a lot of the questions would be answered naturally given the forum and the ability to expand on what they would or could say in a press release update. Should be very informative.
Comment by DeathXray33 on Jun 11, 2023 10:31am
Please STOP HARASSING the Theralase Technologies Inc. management... THANK YOU
Comment by frebeach1 on Jun 11, 2023 3:24pm
What kind of conspiracy to supress knowledge by foolishly trying to intimidate long time investors are you trying to hatch? Theralase is a pulic company and therefore has the reponsibility to bring investors up to date. Keep trolling and you will be put out to pasture. Dave Fleming at Bare Oaks
Comment by Alamir1111 on Jun 11, 2023 6:00pm
Last couple of years we had promising characters joining .like Shiraz,  Trikola, Vera, now Lbiati any bets how long she wll last?or there's a master of puppets pulling the strings?
Comment by O12009 on Jun 11, 2023 6:20pm
She will be there until the buyout or longer if it's a joint venture.
Comment by Alamir1111 on Jun 11, 2023 6:41pm
So according to your wording buyout will be first if that don't happen than we get jv? Guess that is the 11th question for agm
Comment by skys1 on Jun 11, 2023 9:14pm
Alamir, disagree that Shiraz & Trikola were promising
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250